Skip to content

Blood Collection Biorepository for Liver Disease Research

Virology, Immunology and Mechanisms of Liver Disease in Patients With Hepatitis C and Other Liver Diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03025074
Enrollment
1000
Registered
2017-01-19
Start date
2013-07-31
Completion date
2099-12-31
Last updated
2025-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery Candidate, Cirrhosis, Fatty Liver, Fibrosis, Hepatitis B, Hepatitis C, Non-Alcoholic Steatohepatitis(NASH), Obesity, Childhood

Keywords

Liver Disease, Obesity, Hepatitis, HIV, Hepatology

Brief summary

The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.

Detailed description

The Biorepository at the University at Buffalo has been established to collect biological samples from patients with various types of liver disease. The objectives of this biorepository are to stimulate collaboration between clinicians and researchers, to bolster training of junior investigators and to promote multidisciplinary integration to advance translational medicine and to improve the health of patients all over the country. The purpose of this biorepository is to support investigators and to provide them with high quality specimens to promote their efforts in new discoveries or perfecting treatment of patients with liver diseases caused by Non-Alcoholic Fatty Liver Disease (NAFLD), Non-Alcoholic Steatohepatitis (NASH), Hepatitis C Virus (HCV), Hepatitis B Virus (HBV), and Human Immunodeficiency Virus (HIV). The goal is to obtain samples that represent patients seen in the clinics of medical centers in Western NY and from some of the rarer diseases encountered in these clinics. The ultimate goal is to develop the biorepository as Western New York's resource for clinically annotated human samples that can be used to conduct research that could lead to significant advances in patient care.

Interventions

None listed

Sponsors

State University of New York at Buffalo
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
7 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* This protocol is to establish a biobank of blood samples from individuals with or without liver diseases including viral hepatitis, liver cancer, NASH, and negative control samples. * Children and teenagers will be special populations considered in this protocol.

Exclusion criteria

* Vulnerable populations such as adults unable to consent, infants, pregnant women or prisoners will not be considered for this research study.

Design outcomes

Primary

MeasureTime frameDescription
Number of samples collected52 weeksTotal number of samples collected

Countries

United States

Contacts

Primary ContactBarbara Bauer, BA
bmbauer@buffalo.edu716-888-4825

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026